Diabetes/Biliary Disorders. By Diana Blum MSN Metropolitan Community College. Definition . Disorder of carbohydrate, protein, and fat metabolism resulting from an imbalance between insulin availability and need.
Une image / un lien ci-dessous est fourni (tel quel) pour télécharger la présentation
Politique de téléchargement : le contenu du site vous est fourni TEL QUEL pour votre information et votre usage personnel ; il ne peut être vendu, concédé sous licence ni partagé sur d’autres sites sans l’accord de son auteur.Le contenu vous est fourni TEL QUEL, pour votre information et votre usage personnel uniquement.Téléchargez la présentation en cliquant sur ce lien.Lors du téléchargement, si vous ne parvenez pas à télécharger une présentation, l’éditeur a peut-être supprimé le fichier de son serveur.Pendant le téléchargement, si vous ne parvenez pas à obtenir une présentation, le fichier a peut-être été supprimé par l’éditeur.
Definition • Disorder of carbohydrate, protein, and fat metabolism resulting from an imbalance between insulin availability and need. • Group of metabolic diseases characterized by increased levels of glucose in the blood (hyperglycemia) resulting from defects in insulin secretion, insulin action, or both
Statistics • Third leading cause of death • Becoming more common • 285 million people globally currently have • 1/3 of which are undiagnosed • By 2030 it will exceed 438 million • More elderly have (ages 65-74) • Prevalent in Caucasians, African Americans, Native Americans, and Hispanics • Leading cause of : • Non traumatic amputations, blindness, and ESRD
Risk Factors • Family history • Obesity • Ethnicity • Age >45 • HTN • Lipid profile abnormalities • Gestational diabetes
Insulin • Anabolic Hormone produced by beta cells in the islets of langerhans in the pancreas • Transports and metabolizes glucose for energy • Signals the liver to stop the release of glucose • Prevents fat and glycogen breakdown • Enhances dietary fat storage in adipose • Increases protein synthesis • Controls level of glucose in blood • Regulates production of • Regulates storage of glucagon
Diabetes • Cells stop responding to insulin • Pancreas may stop producing Both lead to Hyperglycemia and complications like DKA and HHNS
Type 1 AKA juvenile onset • Insulin dependent(natural level low or absent) • Needed to prevent ketosis and to normalize lipid and protein metabolism. • Autoimmune process that destroys beta cells of the pancreas • Decreasing insulin production, unchecked glucose production by the liver, and fasting hyperglycemia • Can not store glucose from food • Contributes to fat breakdown, increased ketones (byproducts of fat breakdown) • Genetics play role • Can occur at any age but typically less then 3o • Usually have a thin stature and abrupt symptom onset • Prone to DKA • May be triggered by virus or toxins
Type 2 • Non insulin dependent Diabetes • Pancreas retains some function but resistance to insulin is a major cause • Insulin becomes less effective at stimulating glucose uptake by tissues and regulating glucose release by liver • Genetics may play role • Obesity also plays a role • Usually onset after 30 • Can take oral nasal or sq insulin
GOAL: • Euglycemia and to prevent complications Treatment: wt reduction, exercise, diet modification, oral hypoglycemic agents, insulin shots
Gestational • Glucose intolerance associated with pregnancy • 2-10% women annually • Related to secretion of placental hormones which cause insulin resistance • At risk: obese, history of gestational diabetes, glycosuria, stillbirth or abortion, and fam history • TX: diet modifications, insulin
PreDiabetes • Normal glucose metabolism • Obesity • Previous personal history of hyperglycemia
Pancreas • Exocrine: produces digestive enzymes, functions carried out by acinar tissue (grape like clusters that contain pancreatic fluid) • Excretions are alkaline in nature- high sodium bicarb • Amylase, trypsin, lipase • Secretin is a major stimulus to increase bicarb secretion in pancreas • Vagus nerve is also influential
Pancreas • Anatomy • Fish shaped in ULQ behind stomach • Endocrine and exocrine functions • Endocrine: secretes blood hormones to regulate blood sugar • Islets of langerhans are collection of alpha, beta, and delta cells • Beta cells produce insulin (lowers sugar) • Alpha cells secrete glucagon (raises sugar) • Delta cells secrete somatostatin (increases sugar)
Glucose • Circulates in the blood • Major sources of: • Ingested food absorption in GI tract • Production in liver from food substances
Glucagon • Secreted by alpha cells in islets of Langerhans • Stimulates conversion of glycogen to glucose in the liver • GOAL: protect the brain and heart • Mobilize glucose stores from the liver
Glucose Metabolism • Liver helps maintain blood glucose and serves to store it. • Liver takes up excess glucose after meal • Glycogenesis} glucose molecules taken up combined, and then stored as glycogen • Glycogenolysis} when glucose levels in blood falls • Gluconeogenesis} fats and protein broken down in response to low serum glucose levels and molecules used to make e glucose
3 P’s} polyuria, polydipsia, polyphagia • Fatigue • Weakness • Sudden vision changes • Tingling/numbness of hands or feet • Dry skin • Slow to heal wounds • Recurrent infections
Diagnosis criteria • Random glucose test >200mg/dL • 3 P’s • Fasting glucose >126mg/dL • Glucose tolerance test>200mg/dL 2 hours post • Begin screen at age 45 • Screen <45 if: obese, sedentary, close relative with diabetes, high risk ethnic, babies born >9 pounds, HTN, cholesterol issues
American Diabetes Association Glycemic Goals: • HbA1C goal: <7 % (6% is upper limit for normal) without signif. Hypoglycemia • Preprandial glucose: 90-130 mg/dL • Postprandial (peak 11/2 hour) 180 mg/dL • 50% of the blood glucose values within target (70 to 140 mg/dL) • No more than 30% of readings above 200 • No more than 1 or 2 mild hypoglycemic episodes per 1 to 2 weeks
ADA glycemic goals (continued): • LDL <100 mg/dL • Triglycerides <150 mg/dL • HDL >40 for males, >50 for females • Blood pressure: <130/80 with no signs of orthostatic hypotension • Minimal to no peripheral edema • Urinary albumin excretion <30 • Retention of recognition of hypoglycemia
MEDS • Insulin used to be from pork or bovine • Now it is synthetic
IV contains 125 units of regular insulin in 250 ml of NS infusing at 8 ml/hr for a pt with diabetes and pancreatitis. This delivers a dose of how many units per hour? • A. 2 unit/hr • B. 4 unit/hr • C. 6 unit/hr • D. 8 unit/hr
Insulin • A polypeptide (so would degrade in GI tract) • Human insulin is produced by DNA technology through strains of EColi or Yeast • By modifying amino acid sequence gives Insulin different properties • Concentration: • 100 Units/ml • 500 Units/ml Regular Insulin for insulin resistance (but due to conc. Mimics intermed acting)
What is the most serious adverse reaction to insulin? ________________ Insulin preparations vary in their times of onset and duration of activity. - - this is due to the size & composition of insulin crystals in the preparations and the amino acid sequence of the polypeptides. (the less soluble the insulin is, the LONGER is it’s action)
Insulin types • Rapid acting • Short acting • Intermediate acting • Long acting • Insulin combinations
What can affect the absorption of Insulin? • a. _____________ • b.______________ • c.______________ • d.______________ • Insulin is inactivated by, insulinase, an enzyme in the liver.
Route of Insulin admin. (continued) • Regular insulin for drip • used to treat acute hyperglycemia, ketoacidosis, HHS • Continuous subcutaneous infusion pumps: • used with rapid acting insulin infused at low dose to deliver basal insulin and get deliver bolus for postprandial blood glucose control • requires MUCH TRAINING
Connexion au compte
Connectez-vous pour publier votre contenu sur SlideServe.